- Staat
- CA
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 25.05.2023
- Impfdatum
- 15.05.2023
- Beginn
- 15.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Presyncope
Seizure like phenomena
Symptomtext
PT STARTED TO HAVE WHAT LOOKED LIKE A VASO VAGAL RESPONSE. HE STARTED TO LEAN BACK FURTHER ON HIS CAR AND LOOKED LIKE HE WAS HAVING A SEIZURE. HE HAD SOMEONE ELSE WITH HIM AT THE PHARMACY WAITING OUTSIDE. I CALLED HER TO THE VACCINE ROOM. I CALLED EMS IMMEDIATELY AND HE LOST CONSCIOUSNESS WHILE I WAS ON THE PHONE FOR 5 MINUTES OR SO. HE REGAINED CONSCIOUSNESS WHILE I WAS ON THE PHONE WITH EMS. PARAMEDICS ARRIVED AND THEY DID VITALS AND HE WAS CLEARED TO GO
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- PARAMEDICS DID VITAL TESTS AND HE WAS CLEARED TO GO
- Aktuelle Erkrankungen
- NONE KNOWN
- Vorgeschichte
- PT DID INFORM PHARMACIST THAT HE HAD DIZZINESS/FAINT REACTION WITH PRIOR VACCINES. HE WAS INFORMED THAT HE WOULD NEED TO WAI 15 MINUTES AFTER VACCINATION TO SEE IF HE HAS A REACTION
- Andere Medikamente
- NONE KNOWN ACCORDING TO PROFILE
- Allergien
- NO KNOWN DRUG ALLERGY ON FILE.
- Vorherige Impfungen
- PT DID FILL OUT HIS CONSENT FORM AND INFORMED PHARMACIST THAT HE HAS FELT DIZZY AFTER IMMUNIZATION. I INFORMED HIM THAT HE HAD T
- Staat
- -
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 11.12.2023
- Impfdatum
- 11.12.2023
- Beginn
- 11.12.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Angioedema
Dyspnoea
Paraesthesia oral
Wheezing
Symptomtext
Pt received YF, JEV, Anthrax and typhoid vaccines at about 1045 waited in area x 15 minutes. Left to barracks, started feeling tingling sensation in his lips, then started having difficulty breathing. Called his supervisor to inform of sx, advised to return to vaccination location where he was noted to have facial angioedema and audible wheezing at 1120 am. Vitals signs obtained BP: 136/78 HR 113 RR: 21. Epipen administered in Left thigh Symptoms subsided 5 minutes after Epipen administered Pt then escorted to the ER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 18.05.2023
- Impfdatum
- 09.05.2023
- Beginn
- 16.05.2023
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Paraesthesia
Symptomtext
Patient called with c/o tingling sensation above right AC area. Denies any associated pain, swelling, fever, SOB, itching. Tingling started about 1 wk post administration of vaccines. Advised to f/u with PCP with any worsening or non-resolution of tingling within the next few days. Advised to apply warm compresses to the area as needed and avoid cold compresses.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- Tri-Ortho BCP
- Allergien
- None reported
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 17.10.2023
- Impfdatum
- 12.09.2023
- Beginn
- 14.09.2023
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
Client states she developed redness near the injection site with swelling. Mildly warm to the touch. Denied itching. She stated the redness and swelling lasted for one week before fading away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Multi vitamin
- Allergien
- PCN
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 15.08.2023
- Impfdatum
- 10.08.2023
- Beginn
- 11.08.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Injection site erythema
Injection site pain
Injection site pruritus
Symptomtext
Starting on 8/11/2023 redness, itching, soreness to touch around injection site, first 24 hours 2X2 inches, 8/12/2023 doubled in size, on 8/13/2023 redness itching, and soreness had spread shoulder to elbow and half the circumference of the patients arm. Seen at urgent care on 8/13/2023 and treated predisone five day course of 20 mg tablets, Zyrtec daily, cephalexon 5 day course.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma, ezema
- Andere Medikamente
- ALberuterol Inhaler as needed, birth control nexplanon
- Allergien
- Medication allergies, almonds, strawberries, soy, cat and mice allergies.
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 14.08.2023
- Impfdatum
- 14.08.2023
- Beginn
- 14.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Rash
Symptomtext
Pt received yellow fever vaccine about 10-15 min prior to coming to office. Pt presented with diffuse mild rash on inner forearms bilaterally and localized redness at injection site. Pt denies SOB, chest tightness, throat swelling, difficulty breathing. Provider consulted and recommended benadryl and monitoring. Pt agreeable.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Pt given benadryl
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 07.08.2023
- Impfdatum
- 27.07.2023
- Beginn
- 03.08.2023
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dysphagia
Injection site pain
Injection site swelling
Throat tightness
Symptomtext
On Aug 3, 7 days after recieving vaccine, client notified office that she had lots of swelling and pain at injection site and that she was having trouble swallowing and that her throat felt thick. Client was in out of town at the time and information was relayes via email. Client was advised to take 25mg Benadryl every 6 hours and then given the number for to call for reputeable medical professionals near her.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- anxiety
- Andere Medikamente
- On no medications or over the counter supplements at time of vaccination
- Allergien
- NKDA but has seasonal allergies to dust, grass and mold
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 02.08.2023
- Impfdatum
- 01.07.2023
- Beginn
- 14.07.2023
- Tage bis Beginn
- 13,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain
Alanine aminotransferase increased
Antinuclear antibody positive
Aspartate aminotransferase increased
Biopsy bone marrow
Blood alkaline phosphatase increased
Blood bilirubin
Blood creatinine increased
Blood lactate dehydrogenase increased
Blood smear test abnormal
Borrelia test negative
C-reactive protein
Chromaturia
Complement factor C3
Complement factor C4
Coxiella test
Diarrhoea
Faeces discoloured
Symptomtext
58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy. YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures 7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms. On admission ALT 749 AST 290, AlK Phos 375, bili 3.8. Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis. Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved. No bleeding issues normal PT by report. Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118 Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell. PMH HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- 8,0
- Labordaten
- Negative HAV IgM, neg HBsAg, neg HBcIgM, neg HCV Ab, neg Hep E IgM Negative RMSF IgG/IgM, Neg typhus IgG/IgM Positive ANA screen + RNP autoantibody, neg smooth muscle ab negative Normal C3, C4 levels Neg Q fever Ab peripheral blood smear reactive lyphocyties Throbocytopenia 110's-120's Ferritin elevated 1,364 B burgdorferi antibodies neg CRP 5.4 LDH elevated 400-500s Normal immunoglobulin profile HIV 1/2 neg
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- hypertension
- Andere Medikamente
- none
- Allergien
- sulfa antibiotics
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 02.08.2023
- Impfdatum
- 24.07.2023
- Beginn
- 02.08.2023
- Tage bis Beginn
- 9,0
- Dosis
- N/A
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site reaction
Injection site swelling
Injection site warmth
Symptomtext
Today worker woke up and noticed a reddened warm area at vaccine site. Worker seen by the Health Center today. localized reaction to left upper are at site of vaccine. Site 4.5 cm redden, warm and slightly raised in a rough circular pattern. Worker denies pain, itching to site. Worker denies any other symptoms denies resp distress, denies having any fever or chills, itching, swelling of tongue. Ice to area Follow up with the Health center on Friday 8/4/23
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site reaction
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Denies
- Vorgeschichte
- acid reflux
- Andere Medikamente
- Omeprazole 20mg Daily for acid reflux
- Allergien
- denies
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 20.06.2023
- Impfdatum
- 08.06.2023
- Beginn
- 11.06.2023
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Injection site pruritus
Injection site reaction
Injection site swelling
Vaccination site pruritus
Vaccination site swelling
Symptomtext
color of the swelling area is unknown to the reporter but that the area is a little itchy; swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day; feeling fatigued; Initial information received on 14-Jun-2023 regarding an unsolicited valid non-serious case received from a nurse. This case involves 51 years old female patient for whom color of the swelling area is unknown to the reporter but that the area is a little itchy, swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day and feeling fatigued after receiving vaccine yellow fever vaccine [YF-VAX]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included typhoid vaccine live oral for Prophylactic vaccination. On 08-Jun-2023, the patient received a standard dose of suspect yellow fever vaccine Solution for injection at a dose of 0.5 ml total (lot UJ819AA, expiry date- 18-APR-2024) via subcutaneous route in the left arm for Immunization On 11-Jun-2023, (latency- 3 days ), the patient developed a non-serious event of color of the swelling area is unknown to the reporter but that the area is a little itchy (vaccination site pruritus), swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm\area started smaller but is getting bigger every day (vaccination site swelling) and feeling fatigued (fatigue) following the administration of yellow fever vaccine. Relevant laboratory test results included: Physical examination - On 11-Jun-2023: [swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm] Action taken was not applicable. It was not reported if the patient received a corrective treatment for the events At time of reporting, the outcome was Not Recovered / Not Resolved for all the events.; Sender's Comments: US-SA-2023SA184227:01653953
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Test Date: 20230611; Test Name: physical examination; Result Unstructured Data: swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 10.06.2023
- Impfdatum
- 03.06.2023
- Beginn
- 03.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Hypersensitivity
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
Patient is experiencing increased redness, tenderness and a bump increasing in size at the injection site one-week after injection. Pharmacist recommended that patient go to Urgent Care to receive care for potential allergic reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 07.05.2023
- Impfdatum
- 24.04.2023
- Beginn
- 27.04.2023
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test normal
Computerised tomogram normal
Dizziness
Fatigue
Head discomfort
Laboratory test normal
Nausea
Visual impairment
Vitreous floaters
Symptomtext
Started feeling fatigue after the first few days post injection. Over the last week he started feeling dizziness, head pressure, and nausea that might be caused by visual impairment. He is seeing "floaters". He was seen by a doctor who also contacted an infectious disease doctor. They did CT scan, bloodwork, and routine eye exam and all were normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- CT scan, bloodwork, eye exam (time frame 5/1-5/5)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 01.11.2023
- Impfdatum
- 20.10.2023
- Beginn
- 20.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
Medication error
No adverse event
Wrong product administered
Symptomtext
patient came in for a typhoid fever vaccine but was given yf-vax intramuscularly instead of subcutaneously with no reported adverse event; patient came in for a typhoid fever vaccine but was given yf-vax intramuscularly instead of subcutaneously with no reported adverse event; Initial information received on 20-Oct-2023 regarding an unsolicited valid non-serious case received from a nurse. This case is linked to cases 2023SA326767 and 2023SA326868. This case involves a 38 years old male patient who came in for a Typhoid fever Vaccine but was given Yellow Fever Vaccine - [Yf-Vax] intramuscularly instead of subcutaneously with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis b vaccine (hepatitis b vaccine) for Prophylactic vaccination. On 20-Oct-2023, the patient received 0.5 ml total (Dose 1) (1 X) of suspect Yellow Fever Vaccine - Solution for injection (lot number: UJ819AA, Expiry date: 18-Apr-2024) (Strength: standard) (Frequency: once) via intramuscular route in the arm nos (not otherwise specified) for immunisation. On 20-Oct-2023, the patient came in for a typhoid fever vaccine but was given Yellow Fever Vaccine - [Yf-Vax] intramuscularly instead of subcutaneously with no reported adverse event (incorrect route of product administration) (wrong product administered) (latency: same day). It was reported, Nurse called to advise that patient came in for a typhoid fever vaccine but was given YF-VAX intramuscularly instead of subcutaneously. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HEPATITIS B VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 30.10.2023
- Impfdatum
- 20.10.2023
- Beginn
- 20.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Wrong product administered
Symptomtext
came in for a typhoid fever vaccine but was given YF-VAX with no reported adverse event; given YF-VAX intramuscularly instead of subcutaneously with no reported adverse event; Initial information received on 20-Oct-2023 regarding an unsolicited valid non-serious case received via Nurse. This case is linked to cases 2023SA326768(CLUSTER) and 2023SA326868(CLUSTER). This case involves a 12-year-old male patient and reporter reported came in for a typhoid fever vaccine but was given yellow fever vaccine - [YF-VAX] with no reported adverse event and given yf-vax intramuscularly instead of subcutaneously with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 20-Oct-2023, the patient received 0.5 ml total dose of suspect yellow fever vaccine, Solution for injection (lot: UJ819AA, expiry date: 18-Apr-2024) (strength: unknown) via intramuscular route in the arm nos for immunization and came in for a typhoid fever vaccine but was given yf-vax with no reported adverse event (wrong product administered) and yf-vax intramuscularly instead of subcutaneously with no reported adverse event (incorrect route of product administration) (latency: same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 9,0
- Geschlecht
- M
- Eingang
- 28.10.2023
- Impfdatum
- 20.10.2023
- Beginn
- 20.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
Medication error
No adverse event
Wrong product administered
Symptomtext
patient came in for a typhoid fever vaccine but was given yf-vax intramuscularly instead of subcutaneously with no reported adverse event; patient came in for a typhoid fever vaccine but was given yf-vax intramuscularly instead of subcutaneously with no reported adverse event; Initial information received on 20-Oct-2023 regarding an unsolicited valid non-serious case received from a nurse. This case is linked to cases 2023SA326768(CLUSTER) and 2023SA326767(CLUSTER). This case involves a 9 years old male patient who came in for a typhoid fever vaccine but was given yellow fever vaccine - [YF-VAX] intramuscularly instead of subcutaneously with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 20-Oct-2023, the patient came in for a typhoid fever vaccine but received 0.5 ml (dose 1) of suspect yellow fever vaccine, Solution for injection, (lot UJ819AA; Expiration Date : 18-APR-2024: strength not reported) via intramuscular route in the arm nos (unknown if left or right) instead of subcutaneously with no reported adverse event (incorrect route of product administration) (wrong product administered) (latency on same day). Action taken: not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 20.05.2023
- Impfdatum
- 20.05.2023
- Beginn
- 20.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect route of product administration
Symptomtext
Administered vaccination IM instead of subcutaneously
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -